A placebo-controlled safety and tolerability study of intravenous (IV) and subcutaneous (SC) AZD1163 in healthy volunteers

Trial Identifier: D9640C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: November 2023
Primary Completion Date: January 2026
Study Completion Date: January 2026
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Berlin, DE, 14050
US, CA Glendale, CA, US, 91206
US, MD Brooklyn, MD, US, 21225